Part 4: Today’s Most Promising Drug Targets
43 Experts Weigh in on the Most Promising Disease-Modifying Therapies in PD
All posts tagged: drug targets
Part 3: A Crash Course in Drug Development
The Most Important Hurdles To Getting a Drug to Market
Interview With Former Pharmaceutical Executive Dr. Kalpana Merchant
on The Divide Between Academia and Industry, Speeding Up Therapeutic Development, and more
Notes From a Behind the Scenes Look at Roche
The Role of Big Pharma and the Quest for a Cure
